Physle Daily
Neurological Rehab Randomised controlled trial

tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy.

Aphasia after stroke or brain injury can be one of the most frustrating consequences to treat, and clinicians have been looking for ways to boost the effects of standard speech-language therapy. This study compared three approaches in 90 patients with aphasia from stroke or traumatic brain injury: brain stimulation alone using transcranial direct current stimulation, speech-language therapy alone, and the two combined, over five months of treatment. All three groups improved on language tests, but the combined group showed the largest gains in verbal expression, comprehension, and reading, and also outperformed either treatment given alone.

Stimulation alone also outperformed therapy alone. This is an interesting signal that pairing brain stimulation with conventional therapy may add something therapy alone does not, but the trial is moderate in size, and the abstract does not describe blinding or how dropout and long-term retention of gains were handled, so these results should be seen as an early comparative signal rather than settled practice guidance.

If you or someone you know is living with aphasia, communication difficulties after a stroke or brain injury, you may wonder whether combining treatments could help more than speech therapy alone. This study looked at 90 people with aphasia, splitting them into three groups: one received a mild electrical brain stimulation technique alone, one received standard speech-language therapy alone, and one received both together, over five months.

Everyone improved on language tests, which is encouraging, but the group getting both treatments together showed the biggest improvements in things like speaking, understanding language, and reading, and people in that group also reported feeling more confident communicating day to day. Stimulation alone also outperformed therapy alone.

That said, this is one moderately sized trial, and the summary available does not tell us how blinding was handled or whether these improvements lasted after treatment ended. So while the combination approach looks promising here, it is too early to know how reliable or lasting this benefit would be for any given person.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This randomized trial allocated 90 patients with stroke- or traumatic brain injury-related aphasia to three arms: transcranial direct current stimulation (tDCS) alone, speech-language therapy (SLT) alone, or combined tDCS plus SLT, with treatment delivered over five months and tDCS targeting F3 and F4 prefrontal sites at 1 to 1.5 mA for 30 to 40 minutes per session. All three groups showed statistically significant within-group improvement (p < 0.001) on the Frenchay Aphasia Screening Test, Aphasia Evaluation Scale, and Token Test.

Between-group comparisons favored the combined arm, with a 32.6% improvement in Frenchay scores versus 24.3% for tDCS alone and 17.8% for SLT alone, and tDCS alone outperformed SLT alone (p = 0.04), suggesting an additive or synergistic effect of pairing stimulation with therapy.control condcondition for tDCS, or details on dropout, adherence, or duration of follow-up after treatment ended, so durability of the reported gains is unknown. No adverse event data were reported in the abstract.

These findings support further investigation into combined neuromodulation and behavioral therapy protocols but do not yet establish an evidence base robust enough to inform firm clinical recommendations.

1

Combined tDCS plus speech-language therapy produced the largest improvement in language function, a 32.6% gain on the Frenchay Aphasia Screening Test, compared with 24.3% for stimulation alone and 17.8% for therapy alone.

2

Transcranial direct current stimulation alone significantly outperformed speech-language therapy alone (p = 0.04), suggesting the stimulation itself contributed measurable benefit beyond therapy.

3

This is a single moderately sized trial of 90 patients without reported details on blinding or long-term follow-up, so the durability and generalizability of the combined-treatment advantage remain uncertain.

Source

Medical science monitor : international medical journal of experimental and clinical research

Twardochleb Z, Szczepańska M, Miś MM et al. · 2025

doi: 10.12659/MSM.950237

Read paper →
Previously in Neurological
2026-08-21Impact of Physical Exercise Programs on Fatigue and Functional Capacity in People With Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review.2026-08-20Effects of Balance Exercise Interventions on Balance-Related Performance in People With Multiple Sclerosis: A Systematic Review and a Meta-Analysis of Randomized Controlled Trials.2026-08-19Effects of Exercise in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Browse the full Neurological archive →
A note on accuracy

Summaries are AI-generated from each paper's abstract and are for learning, not clinical decision-making. They may miss nuance or occasionally misstate details from the source, so always read the original paper before applying findings in practice. Nothing on this site is medical advice.